Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/1995
04/05/1995EP0646649A1 Method of producing iturin A and antifungal agent for profund mycosis
04/05/1995EP0646648A1 Method for producing polypeptide
04/05/1995EP0646646A2 Protein expression system
04/05/1995EP0646645A2 A process for producing a substance
04/05/1995EP0646644A2 Periplasmic membrane-bound system for detecting protein-protein interactions
04/05/1995EP0646600A1 A cell growth-inhibiting protein
04/05/1995EP0646378A1 Agent for enhancing the yield of antibodies in immunology
04/05/1995EP0646244A1 Immunoassay and test kit for thrombin-antithrombin iii complex
04/05/1995EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY
04/05/1995EP0646174A1 Recombinant production of saporin-containing proteins
04/05/1995EP0646173A1 Reagent for agglutination assays
04/05/1995EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE
04/05/1995EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use
04/05/1995EP0646129A1 Receptor-type tyrosine kinase-like molecules
04/05/1995EP0646015A1 Contraceptive vaccine
04/05/1995EP0646013A1 Platelet derived growth factor antagonists
04/05/1995EP0549675B1 Detergent containing protease and inhibitor and novel inhibitors for use therein
04/05/1995EP0513161B1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
04/05/1995EP0507839B1 Method of separating haemopoietic progenitor cells
04/05/1995EP0318554B1 Targeted multifunctional proteins
04/05/1995EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor
04/05/1995EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides
04/05/1995CN1028114C Monoclonal antibody specific for adhesion function domain of phagocyte surface protein
04/05/1995CA2133355A1 Method for producing polypeptide
04/04/1995US5403924 Taga gene and methods for detecting predisposition to peptic ulceration
04/04/1995US5403915 Isolation and purification of lung surfactant protein
04/04/1995US5403737 Serine protease variants having peptide ligase activity
04/04/1995US5403734 t-PA with growth factor domain substitutions
04/04/1995US5403718 Methods and antibodies for the immune capture and detection of Borrelia burgdorferi
04/04/1995US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label
04/04/1995US5403581 Administering immunogenic polypeptide to poultry
04/04/1995CA1335083C Fr901228 substance and preparation thereof
04/03/1995EP0672152A4 Fusion proteins comprising mgf and il-3.
03/1995
03/31/1995CA2132937A1 Protein expression system
03/30/1995WO1995008646A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
03/30/1995WO1995008632A1 Immunoreactive antigens of hepatitis e virus
03/30/1995WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites
03/30/1995WO1995008630A1 Surface loop structural analogues of fibroblast growth factors
03/30/1995WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995WO1995008628A2 Nucleic acids encoding merosin, merosin fragments and uses thereof
03/30/1995WO1995008627A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
03/30/1995WO1995008576A1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors
03/30/1995WO1995008570A1 Chimeric proteins which block complement activation
03/30/1995WO1995008554A1 Nf-at polypeptides and polynucleotides
03/30/1995WO1995008343A1 Modified truncated complement system regulators
03/30/1995WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
03/30/1995CA2172610A1 Chimeric proteins which block complement activation
03/30/1995CA2172504A1 Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172385A1 Nucleic acids encoding merosin, merosin fragments and uses thereof
03/30/1995CA2172287A1 Nf-at polypeptides and polynucleotides
03/30/1995CA2171206A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
03/30/1995CA2170521A1 Immunoreactive antigens of hepatitis e virus
03/29/1995EP0645451A1 Heparin binding site structural analogues of fibroblast growth factors
03/29/1995EP0645450A1 Human calcitonin precursor polyprotein structural gene
03/29/1995EP0644948A1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/29/1995EP0644947A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses
03/29/1995EP0644938A1 PRODUCTION OF STREPTAVIDIN FROM $i(BACILLUS SUBTILIS)
03/29/1995EP0644937A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression
03/29/1995EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/29/1995EP0644935A1 DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS
03/29/1995EP0644930A1 Monoclonal antibody against the extra-villous trophoblast
03/29/1995EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
03/29/1995EP0644899A1 Production of recombinant human lactoferrin
03/29/1995EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID
03/29/1995EP0644774A1 Improved production of reproductive hormones
03/29/1995EP0563144B1 Diagnosis for porcine malignant hyperthermia
03/29/1995EP0460190B1 Method for detecting malignant diseases
03/29/1995EP0393045B1 Fv antibody fragment production
03/29/1995EP0374162B1 Balanced constitutive inducible transcription system
03/29/1995EP0332667B1 Vector for integration site independent gene expression in mammalian host cells
03/29/1995CN1100757A Novel plasmid for production of CRM protein and diphtheria toxin
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401721 Antiulcer agents and antisecretory agents
03/28/1995US5401651 DNA encoding ENA-78, a neutrophil activating factor
03/28/1995US5401643 Method of preparing an active human neutrophil chemotactic factor polypeptide
03/28/1995US5401641 Haptans for immune response and isolation
03/28/1995US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof
03/28/1995US5401627 Warts, cancer
03/28/1995CA2012631C Process for the production of hetero-bispecific antibodies
03/28/1995CA1334944C Signal peptide, dna sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
03/28/1995CA1334943C Leader sequence for the production of recombinant proteins
03/28/1995CA1334942C Production of m-csf
03/28/1995CA1334941C Cloning and expression of a host-protective immunogens of ibdv
03/28/1995CA1334940C Production of glucose oxidase in recombinant systems
03/25/1995CA2132668A1 Heparin binding site structural analogues of fibroblast growth factors
03/23/1995WO1995008115A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
03/23/1995WO1995007994A2 Recombinant alphavirus vectors
03/23/1995WO1995007992A2 Cloned glutamic acid decarboxylase
03/23/1995WO1995007987A2 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor
03/23/1995WO1995007986A1 Pharmaceutical compositions containing ecotin and homologs thereof
03/23/1995WO1995007984A1 Human receptor h4-1bb
03/23/1995WO1995007983A1 Human mu opioid receptor
03/23/1995WO1995007982A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995WO1995007978A1 A secretion sequence for the production of a heterologous protein in yeast
03/23/1995WO1995007934A2 Il8 inhibitors
03/23/1995WO1995007933A1 Methods and composition for the modulation of host immune response to allergens
03/23/1995WO1995007931A1 Acylated insulin
03/23/1995WO1995007922A1 Drug binding protein
03/23/1995WO1995007907A1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives